Truffle Capital

Summary

Truffle Capital is the famous VC, which was founded in 2001. The fund was located in Europe if to be more exact in France. The main office of represented VC is situated in the Paris.

The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2012. Speaking about the real fund results, this VC is 28 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Truffle Capital works on 14 percentage points more the average amount of lead investments. The usual things for fund are deals in the range of 5 - 10 millions dollars.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. Among the most successful fund investment fields, there are Financial Services, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Altimmune, CARMAT, Actility. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Truffle Capital, startups are often financed by Ventech, Novartis Venture Fund, Auriga Partners. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Idinvest Partners, Ventech. In the next rounds fund is usually obtained by Idinvest Partners, Novartis Venture Fund, Bpifrance.

The current fund was established by Bernard-Louis Roques, Henri Moulard, Jean-Francois Fourt, Philippe Pouletty. Besides them, we counted 4 critical employees of this fund in our database.